Similar articles

• Management of scleroderma.

  Winkelmann RK, Kierland RR, Perry HD, Muller SA, Sams WM Jr. Winkelmann RK, et al. Mayo Clin Proc. 1971 Feb;46(2):128-34. Mayo Clin Proc. 1971. PMID: 5546412 No abstract available.
• Effect of D-penicillamine on pulmonary fibrosis in patients with systemic sclerosis.

  Jinnin M, Ihn H, Asano Y, Yamane K, Yazawa N, Tamaki K. Jinnin M, et al. Ann Rheum Dis. 2003 Oct;62(10):1019-20. doi: 10.1136/ard.62.10.1019. Ann Rheum Dis. 2003. PMID: 12972489 Free PMC article. Clinical Trial. No abstract available.
• [Treatment of systemic sclerosis].

  van den Hoogen FH. van den Hoogen FH. Z Rheumatol. 2006 Jul;65(4):306, 308-10. doi: 10.1007/s00393-006-0075-y. Z Rheumatol. 2006. PMID: 16819640 Review. German.
• Ankylosing spondylitis and systemic sclerosis: a rare combination.

  Ouédraogo DD, Palazzo E, Nlomé-Nzé M, Somogyi-Demerjian N, Meyer O. Ouédraogo DD, et al. Joint Bone Spine. 2009 May;76(3):290-2. doi: 10.1016/j.jbspin.2006.07.008. Epub 2009 Apr 15. Joint Bone Spine. 2009. PMID: 19372061
• D-penicillamine in systemic sclerosis? Yes!

  Medsger TA Jr, Lucas M, Wildy KS, Baker C. Medsger TA Jr, et al. Scand J Rheumatol. 2001;30(4):192-4. doi: 10.1080/030097401316909503. Scand J Rheumatol. 2001. PMID: 11578011 Review.